← Patent-cliff monitor Loss of exclusivity March 2038 latest FDA-listed patent expiry
Drug detail Brand name AKEEGA Active ingredient ABIRATERONE ACETATE; NIRAPARIB TOSYLATE Strength 500MG;EQ 50MG BASE Dosage form TABLET Route ORAL Modality Small molecule FDA approval August 2023 Marketing status RX
Listed patents Patent Expires Type 11673877 March 2038 substance, product 11091459 March 2038 substance, product 11992486 July 2037 use U-2830 12383543 July 2037 use U-2830 11986470 July 2037 use U-4368 11986468 July 2037 use U-2830 11207311 July 2037 use U-4368 11986469 July 2037 use U-2830 8859562 August 2031 use U-4368 8071623 March 2031 substance, product 8436185 April 2029 substance, product 8143241 August 2027 use U-4368 8071579 August 2027 use U-4368
Regulatory exclusivity Code Expires I-980 December 2028 NP August 2026
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.